Sign inJoin waitlistJoin the waitlist

Ash Tewari

PROFESSOR AND SYSTEM CHAIR | Urology · Icahn School of Medicine at Mount Sinai

Credentials: · · · · · · ·

History

Icahn School of Medicine at Mount Sinai
Present
Urology Department · Icahn School of Medicine at Mount Sinai
Present
Center for Prostate Cancer · Henry Ford Health
Present

Urology
Henry Ford Health
1999–2004
G S V M MED COLL, KANPUR UNIV, KANPUR, UP, INDIA
1980–1984

Research

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Nature Genetics · 2012 · 1,264 citations
Punctuated evolution of prostate cancer genomes
Cell · 2013 · 1,032 citations
The genomic complexity of primary human prostate cancer
Nature · 2011 · 996 citations

Mani Menon
61 papers · 6 as a resident
Peter Wiklund
40 papers
Vinayak Wagaskar
39 papers · 39 as a resident
PS
Prasanna Sooriakumaran
35 papers · 30 as a resident
Alberto Martini
34 papers · 34 as a resident
AS
Abhishek Srivastava
32 papers · 3 as a resident
SL
Sara Lewis
24 papers
ZD
Zach Dovey
24 papers · 23 as a resident
GH
George Haines
23 papers
PN
Perinchery Narayan
21 papers
Ashok Hemal
19 papers
Vipul Patel
19 papers

Grants

EXPAND-PC: Expanding Prostate Cancer Screening and Improving Delivery of Preventive Services in Community Settings
National Institute on Minority Health and Health Disparities · R01
Contact PI · $489.9K · Icahn School of Medicine at Mount Sinai
2026–2031
Molecular Profiling of the Tumor Microenvironment in Prostate Cancer Progression
National Cancer Institute · R01
PI · $1.4M · Icahn School of Medicine at Mount Sinai
2025–2030
Artificial Intelligence Enabled Stroma-Weighted Automated Grading System to Improve Risk Stratification in Black Men
National Cancer Institute · R01
Contact PI · $1.4M · Icahn School of Medicine at Mount Sinai
2025–2030
Real-Time Multiphoton Microscopy of Periprostatic Tissue Architecture
National Institute of Biomedical Imaging and Bioengineering · R01
Contact PI · $851.1K · Weill Medical Coll of Cornell Univ
2009–2013

Clinical trials

Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer
Principal investigator · Recruiting · Phase 2
Icahn School of Medicine at Mount Sinai
2026–2031
Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance
Principal investigator · Recruiting · Phase 2
Icahn School of Medicine at Mount Sinai
2026–2027
Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy Specimen
Principal investigator · Recruiting
Icahn School of Medicine at Mount Sinai
2025–2026
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)
Principal investigator · Recruiting · Phase 3
Icahn School of Medicine at Mount Sinai
2023–2027